Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03279445 · ClinicalTrials.gov registry record
Parkinson's Disease in African American and Caucasian Patients
A clinical trial of Parkinson Disease, sponsored by University of Chicago.
- Completed
- Registry status
- 2,033
- Enrollment target
- 1
- Study location
NCT03279445 is a study of Parkinson Disease that has completed, run by University of Chicago. The registered enrollment target is 2,033 participants, below the 5,320-participant average among 297 other Parkinson Disease trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03279445, a study of Parkinson Disease, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 2,033 participants
- Enrollment target
- 1
- Study location
Study Summary
More than 10 million people worldwide are living with Parkinson's disease (PD). While the actual number of African American (or Black) patients with PD is unknown, it is clear that there are racial disparities in the access to health care, diagnosis, treatment and survival of PD. The lack of clear knowledge on the possibly lower PD prevalence among African Americans compared to Caucasians further calls for more research in this field. The University of Chicago Medicine is an ideal facility to study this topic, due to its location on the South Side of Chicago with a large African American (or Black) population. By analyzing the demographics, socioeconomics and clinical features of PD patients in our Center for Research Informatics in African American (or Black) patients compared to the Caucasians of similar geographical area, the investigators aim to work toward a better understanding of the unique features of PD in American American (or Black) population, which might help improve the healthcare among this population in the Chicago and possibly nationwide as well.
Conditions Studied
Study Locations (1)
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,033 participants |
| Start Date | 2017-08-09 |
| Est. Completion | 2021-04-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03279445
The ClinicalTrials.gov registry entry for NCT03279445 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,033 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,320-participant average among 297 other Parkinson Disease trials with a reported enrollment target (62% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03279445 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03279445 about?
NCT03279445 is a clinical study titled "Parkinson's Disease in African American and Caucasian Patients". More than 10 million people worldwide are living with Parkinson's disease (PD). While the actual number of African American (or Black) patients with PD is unknown, it is clear that there are racial disparities in the access to health care, diagnosis, treatment and survival of PD. The lack of clear k...
What is the current status of trial NCT03279445?
This trial is currently completed. The enrollment target is 2,033 participants. The study started on 2017-08-09. Estimated completion is 2021-04-10.
What conditions does trial NCT03279445 study?
This clinical trial studies the following conditions: Parkinson Disease.
Who is sponsoring clinical trial NCT03279445?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03279445 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.